Vivolux AB
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of VLX1570 and Dexamethasone in Myeloma Patients (NCT02372240) | Vivolux AB | 2015-04-08 |
| Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid Tumors (NCT02222363) | Vivolux AB | 2015-02-18 |
Track Vivolux AB automatically
Every clearance here is in the API, with alerts when new ones post.